Official title and information are available only for Plus and Premium subscribers.
Patent Pending Endoplasmic-reticulum-associated protein degradation (ERAD) designates a cellular pathway which targets misfolded proteins of the endoplasmic reticulum for ubiquitination and subsequent degradation by a protein-degrading complex, called the proteasome.
To see the additional information details please login and subscribe to a Plus or Premium account.
